Onduo, a digital health tool from Alphabet’s life science subsidiary Verily, announced it will be offering Fitbit devices and Fitbit Premium with its chronic disease management platform. Employees who ...
The new, streamlined Verily will have one very recognizable component: its virtual care company Onduo, whose prodigious data collection from chronic disease patients will help power Verily’s ...
Onduo Health, the virtual diabetes coaching program backed by Verily (and to a lesser extent Sanofi), announced this morning that it is expanding its platform beyond Type 2 diabetes to include several ...
BOSTON--(BUSINESS WIRE)--Today, Onduo shared positive research findings from the use of continuous glucose monitoring (CGM) systems by adults with type 2 diabetes participating in its virtual diabetes ...
Blue Cross and Blue Shield plans are partnering with Alphabet-backed Onduo to monitor glucose levels of patients with diabetes using a wearable device the insurers hope will improve health outcomes.
New Partnership Aimed at Providing Personalized Diabetes Support and Management Program Paired with the Protection of Life Insurance and the Potential to Earn up to 25% in Premium Savings TSX/NYSE/PSE ...
BOSTON--(BUSINESS WIRE)--Today, Onduo, part of Verily, Alphabet’s life sciences subsidiary, announced that it will offer Fitbit devices and Fitbit Premium as part of the company’s approach to whole ...
Verily’s Onduo is branching into mental and behavioral health. Onduo virtual telehealth clinic, achieves this goal by allowing individuals are able to access psychiatrists, therapists, and mental ...
Sanofi is looking at ways to revive its flagging diabetes business, and yesterday revealed some of the new ideas it has up its sleeve. The company’s biggest seller is basal insulin Lantus, which ...
Participants involved in a survey conducted by Onduo found continuous glucose monitors (CGM) to be highly effective. The results were presented at the 13 th International Conference on Advanced ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Sanofi’s new CEO laid out plans Tuesday to shake up one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results